Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 9 of 44, showing 5 Applications out of 217 total, starting on record 41, ending on 45

# Protocol No Study Title Investigator(s) & Site(s) Application Status

41.

ECCT/18/11/02   EPI 003
    A prospective study to evaluate the safety, effectiveness and impact of the RTS,S/AS01E vaccine in young children in sub-Saharan Africa.   
Principal Investigator(s)
1. BERNHARDS OGUTU
Site(s) in Kenya
1. • Ahero Clinical Trials Unit (Kisumu county)
2. KEMRI Walter Reed Army Institute of Research (Kisumu county)
3. KEMRI CDC SIAYA (Siaya county)
 
Trial Status Not yet recruiting
Protocol Date 11-10-2017
View

42.

ECCT/18/11/01   PrIMA
              PrEP Implementation for Mothers in Antenatal Care            
Principal Investigator(s)
1. Grace John-Stewart John-Stewart
2. Jared Baeten
Site(s) in Kenya
1. Homa Bay County - 10 sites (Homa Bay county)
2. Siaya County - 10 sites (Siaya county)
 
Trial Status In follow-up
Protocol Date 31-07-2018
View

43.

ECCT/18/10/02   Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya
            Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya    
Principal Investigator(s)
1. Dr. Nelly Rwamba Mugo
2. Dr. Maricianah Atieno Onono
3. Prof Bukusi Anne Bukusi
4. Dr. Betty Wanjiru Njoroge
5. Dr. Ruanne Barnabas
Site(s) in Kenya
1. KEMRI NAIROBI (Nairobi City county)
2. KEMRI KISUMU (Kisumu county)
3. KEMRI THIKA PHRD (Kiambu county)
 
Trial Status In follow-up
Protocol Date 03-08-2018
View

44.

ECCT/18/12/01   study to determine if a new malaria vaccine is safe and induces immunity among Kenyan adults, young children and infants.
    A Phase 1b, open-label, age de-escalation, dose-escalation study to evaluate the safety and immunogenicity of different doses of a candidate malaria vaccine; adjuvanted R21(R21/MM) in adults, young children and infants in Kilifi, Kenya.   
Principal Investigator(s)
1. Mainga Hamaluba
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
 
Trial Status Suspended
Protocol Date 02-10-2018
View

45.

ECCT/18/10/03   UMBIFLOW
    Prevalence and outcomes of abnormal continuous wave Doppler flow indices in unselected obstetric populations in low- and middle-income countries: The Umbiflow International Study.   
Principal Investigator(s)
1. Prof Zahida Parveen Qureshi
Site(s) in Kenya
1. Mbagathi District Hospital (Nairobi City county)
2. St. Mary\'s Hospital (Nairobi City county)
3. Kenyatta National Hospital (Nairobi City county)
 
Trial Status Completed
Protocol Date 21-06-2018
View